BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 22850577)

  • 1. Clinical usefulness of the triaxial system in super-selective transcatheter arterial chemoembolization for hepatocellular carcinoma.
    Shimohira M; Ogino H; Kawai T; Sakurai K; Nakagawa M; Shibamoto Y
    Acta Radiol; 2012 Oct; 53(8):857-61. PubMed ID: 22850577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the triaxial microcatheter method in super-selective transcatheter arterial chemoembolisation for hepatocellular carcinoma.
    Shimohira M; Ogino H; Kawai T; Kushita A; Watanabe M; Kawaguchi T; Kurono K; Shibamoto Y
    Br J Radiol; 2011 Feb; 84(998):184-7. PubMed ID: 21257838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
    Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
    Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of safety and efficacy for transcatheter arterial chemoembolization alone and plus radiofrequency ablation in the treatment of single branch portal vein tumor thrombus of hepatocellular carcinoma and their prognosis factors].
    Zhao M; Wang JP; Li W; Huang ZL; Zhang FJ; Fan WJ; Zhang L; Li XS; Pan CC; Wu PH
    Zhonghua Yi Xue Za Zhi; 2011 May; 91(17):1167-72. PubMed ID: 21756768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma.
    Zhang Z; Liu Q; He J; Yang J; Yang G; Wu M
    Cancer; 2000 Dec; 89(12):2606-12. PubMed ID: 11135222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical effect of transcatheter arterial chemoembolization combined with high intensity focused ultrasound ablation in treatment of large hepatocellular carcinoma].
    Li CX; Wu PH; Fan WJ; Huang JH; Zhang FJ; Zhang L; Gu YK; Zhao M; Gao F; Jiao DC
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(11):754-7. PubMed ID: 19595104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcatheter arterial chemoembolization vs. chemoinfusion for unresectable hepatocellular carcinoma in patients with major portal vein thrombosis.
    Kim JH; Yoon HK; Kim SY; Kim KM; Ko GY; Gwon DI; Sung KB
    Aliment Pharmacol Ther; 2009 Jun; 29(12):1291-8. PubMed ID: 19392861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcatheter arterial chemoembolization plus radiofrequency ablation therapy for early stage hepatocellular carcinoma: comparison with surgical resection.
    Kagawa T; Koizumi J; Kojima S; Nagata N; Numata M; Watanabe N; Watanabe T; Mine T;
    Cancer; 2010 Aug; 116(15):3638-44. PubMed ID: 20564097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response evaluation of transcatheter arterial chemoembolization in hepatocellular carcinomas: the usefulness of sonazoid-enhanced harmonic sonography.
    Xia Y; Kudo M; Minami Y; Hatanaka K; Ueshima K; Chung H; Hagiwara S; Inoue T; Ishikawa E; Kitai S; Takahashi S; Tatsumi C; Ueda T; Hayaishi S; Maekawa K
    Oncology; 2008; 75 Suppl 1():99-105. PubMed ID: 19092278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodality treatment with conventional transcatheter arterial chemoembolization and radiofrequency ablation for unresectable hepatocellular carcinoma.
    Ashoori N; Paprottka P; Trumm C; Bamberg F; Kolligs FT; Rentsch M; Reiser MF; Jakobs TF
    Digestion; 2012; 85(1):18-26. PubMed ID: 22156507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term result of combination of transcatheter arterial chemoembolization and percutaneous ethanol injection for treatment of hepatocellular carcinoma].
    Chen XM; Luo PF; Lin HH; Zhou ZJ; Shao PJ; Fu L; Li WK
    Ai Zheng; 2004 Jul; 23(7):829-32. PubMed ID: 15248922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of hepatitis B exacerbation is low after transcatheter arterial chemoembolization therapy for patients with HBV-related hepatocellular carcinoma: report of a prospective study.
    Park JW; Park KW; Cho SH; Park HS; Lee WJ; Lee DH; Kim CM
    Am J Gastroenterol; 2005 Oct; 100(10):2194-200. PubMed ID: 16181368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinomas 2-3 cm in diameter: transarterial chemoembolization plus radiofrequency ablation vs. radiofrequency ablation alone.
    Kim JW; Kim JH; Won HJ; Shin YM; Yoon HK; Sung KB; Kim PN
    Eur J Radiol; 2012 Mar; 81(3):e189-93. PubMed ID: 21353417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Exploration of indication of prophylactic transcatheter arterial chemoembolization on postoperative recurrence of hepatocellular carcinoma].
    Wang QX; Yan JJ; Zhou FG; Shen J; Yan YQ
    Zhonghua Wai Ke Za Zhi; 2009 May; 47(10):748-51. PubMed ID: 19615209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Transcatheter arterial chemoembolization for hepatocellular carcinoma using 3 French catheter system].
    Mikami K; Osuga K; Nakamura H
    Gan To Kagaku Ryoho; 2009 Jun; 36(6):959-62. PubMed ID: 19542715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A comparison of patients with hepatocellular carcinoma between a short-term (less than 6 months) survival group and a long-term (over 24 months) survival group after treatment with transcatheter arterial chemoembolization].
    Kang IK; Kim SW; Hahn SH; Cho SC; Gham CW; Lee DH
    Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):189-200. PubMed ID: 12499805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete necrosis after transarterial chemoembolization could predict prolonged survival in patients with recurrent intrahepatic hepatocellular carcinoma after curative resection.
    Shim JH; Kim KM; Lee YJ; Ko GY; Yoon HK; Sung KB; Park KM; Lee SG; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
    Ann Surg Oncol; 2010 Mar; 17(3):869-77. PubMed ID: 20033326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experience of the treatment following downstaging of larger hepatocellular carcinomas by transcathetheter hepatic arterial chemoembolization in 58 patients].
    Jin X; Shi XJ; Wang MQ; Wei LX; Ye HY; Liang YR; Luo Y; Dong JH
    Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(14):950-5. PubMed ID: 21609544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study.
    Lee HS; Kim JS; Choi IJ; Chung JW; Park JH; Kim CY
    Cancer; 1997 Jun; 79(11):2087-94. PubMed ID: 9179054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switching the loaded agent from epirubicin to cisplatin: salvage transcatheter arterial chemoembolization with drug-eluting microspheres for unresectable hepatocellular carcinoma.
    Seki A; Hori S
    Cardiovasc Intervent Radiol; 2012 Jun; 35(3):555-62. PubMed ID: 21562932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.